A nurse in an emergency department is caring for a client who has diabetic ketoacidosis (DKA) and a blood glucose level of 925 mg/dL. The nurse should anticipate which of the following prescriptions from the provider?
A.
Oral hypoglycemic medications
B.
0.9% sodium chloride IV bolus
C.
Dextrose 5% in 0.45% sodium chloride
D.
Glucocorticoid medications
The Correct answer and Explanation is:
The correct answer is B. 0.9% sodium chloride IV bolus.
Explanation:
Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus, particularly Type 1 diabetes, characterized by severe hyperglycemia, ketosis, and metabolic acidosis. It occurs due to a deficiency of insulin, leading to the breakdown of fats for energy, producing ketones as a byproduct. The patient’s blood glucose level of 925 mg/dL indicates severe hyperglycemia, and urgent medical intervention is required.
Why 0.9% Sodium Chloride IV Bolus?
One of the primary concerns in DKA is dehydration, as hyperglycemia leads to osmotic diuresis, causing excessive loss of water and electrolytes through urine. Administering 0.9% sodium chloride (normal saline) via IV bolus is essential because:
- Fluid replacement: Rehydration is the first step in managing DKA. It helps restore blood volume, improve tissue perfusion, and reduce glucose concentration in the blood by dilution. The fluid also supports kidney function, helping the body clear excess glucose and ketones.
- Correcting electrolyte imbalance: Sodium chloride helps correct the electrolyte imbalances commonly seen in DKA. Hypovolemia from fluid loss can lead to dangerous electrolyte shifts, and replenishing fluids is crucial to stabilizing sodium and potassium levels.
Why Not Other Options?
- A. Oral hypoglycemic medications: These medications are typically used for managing Type 2 diabetes and are ineffective in DKA. Since insulin deficiency is the root cause of DKA, oral agents cannot restore the needed insulin levels. Instead, insulin administration is necessary.
- C. Dextrose 5% in 0.45% sodium chloride: This fluid contains glucose, which would not be appropriate during the initial management of DKA, as the goal is to lower blood glucose levels. Once the glucose level drops to around 250 mg/dL, dextrose-containing fluids may be used to prevent hypoglycemia while continuing insulin therapy.
- D. Glucocorticoid medications: Glucocorticoids are steroids that can increase blood glucose levels. They are not indicated in the treatment of DKA and would exacerbate the hyperglycemia.
Additional Management of DKA:
- Insulin therapy: After fluid resuscitation, regular insulin is administered intravenously to reduce blood glucose and ketone levels. Insulin stops ketone production by allowing glucose to enter the cells for energy.
- Potassium monitoring: Potassium levels can fluctuate during treatment. As insulin therapy begins, potassium shifts into cells, which can cause hypokalemia (low potassium). Therefore, potassium replacement may be necessary.
- Bicarbonate therapy: In severe cases of acidosis, bicarbonate may be administered to correct the pH imbalance, but this is not a routine intervention unless acidosis is profound.
In summary, the immediate priority in DKA management is restoring circulatory volume and stabilizing electrolytes through aggressive fluid replacement with 0.9% sodium chloride IV bolus. This intervention, followed by insulin therapy, addresses the underlying causes of DKA and prevents life-threatening complications.